Vanda Pharmaceuticals Inc. ($VNDA)
Filing Information
| Accession Number | 0001193125-26-059792 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 19, 2026 |
| Document Date | Feb 18, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
125,000
Total Value
$0.00
P&L
+inf% (+$1,101,250.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SVP, Chief Marketing Officer | Common Stock | โ | Feb 18, 2026 | Grant/Award | 125,000 | $0.00 | $0.00 | 364,269 | Direct | โ | View Details |